Bright Minds Biosciences Inc. DRUG
23.00 USD +2.30 (+11.11%)
At closeNov 6, 2026, 6:56 PM EST
22.70 -0.30 -1.30%
After hours · Nov 6, 6:56 PM ET
20.71 Day range 23.39
18.96 52-week range 95.99
- YTD
- -70.53%
- 1 year
- -59.01%
Financial health
Altman Z-Score
75.95 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C+2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 2
Valuation
P/E -47.4×
FY 2019 5y median -2.4× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 7.1×
FY 2019 5y median 2.0× FY 2025
P/FCF -66.8×
FY 2019 5y median -3.7× FY 2025
EV/EBITDA -41.0×
FY 2019 5y median -0.6× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -1.5%
FY 2019 5y median -27.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -14.9%
FY 2019 5y median -50.6% FY 2025
ROIC -17.0%
FY 2019 5y median -49.9% FY 2025
ROA -14.5%
FY 2019 5y median -45.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -393.8%
FY 2019 FY 2025
EPS (diluted) -173.8%
FY 2019 FY 2025
Free Cash Flow -369.8%
FY 2019 FY 2025
Financial Health
Current Ratio 36.1×
FY 2019 5y median 24.3× FY 2025
Quick Ratio 36.1×
FY 2019 5y median 24.3× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 6.8×
FY 2019 5y median 2.1× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-09-30